Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2018-11-29 2018-05-28
Drug Identification Number 02126745 02126745
Brand name AMINOSYN II AMINOSYN II
Common or Proper name Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free) Aminosyn™ II 15% Amino Acid for Injection (Sulfite-free)
Company Name ICU MEDICAL CANADA INC ICU MEDICAL CANADA INC
Ingredients HISTIDINE TRYPTOPHAN N-ACETYL-L-TYROSINE L-LYSINE L-ALANINE METHIONINE GLYCINE GLUTAMIC ACID L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE SERINE HISTIDINE TRYPTOPHAN N-ACETYL-L-TYROSINE L-LYSINE L-ALANINE METHIONINE GLYCINE GLUTAMIC ACID L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE SERINE
Strength(s) 450MG 300MG 405MG 1.575G 1.49G 258MG 750MG 1.107G 1.083G 1.527G 750MG 1.05G 600MG 447MG 1.5G 990MG 795MG 450MG 300MG 405MG 1.575G 1.49G 258MG 750MG 1.107G 1.083G 1.527G 750MG 1.05G 600MG 447MG 1.5G 990MG 795MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2000ML 2000ML
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-06-05 2017-06-05
Actual start date 2017-06-05 2017-06-05
Estimated end date 2019-01-31 2019-01-31
Actual end date 2018-10-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments